Fibroblasts as a practical alternative to mesenchymal stem cells

Journal of Transitional Medicine Our Chief Scientific Officer, Thomas Ichim, Ph.D. led a team in a thorough analysis of the advantage fibroblasts exhibit over mesenchymal stem cells. Read Full Article

Therapeutic effects of cell therapy with neonatal human dermal fibroblasts and rabbit dermal fibroblasts on disc degeneration and inflammation

The Spine Journal Howard An, M.D. leads a team of researchers who found that transplanting dermal fibroblasts can significantly increase the markers of disc regeneration and supported the hypothesis that the intervertebral disc is immune privileged. The study also suggests that fibroblast cell therapies can prevent the degeneration and promote the regeneration of the spinal […]

Cell Therapy with Human Dermal Fibroblasts Enhances Intervertebral Disk Repair and Decreases Inflammation in the Rabbit Model

Global Spine Journal A team of scientists led by Howard An, M.D. proves human dermal fibroblasts are a promising future for treatment of degenerative disc disease. Read Full Article